Orthodontic Supplies Market - Global Industry Analysis, Size, Share and Growth, 2023

The global orthodontic supplies market is likely to grow from $3.4 billion in 2016 to $5.9 billion by 2023. The demand for orthodontic supplies is on a surge mainly due to increasing prevalence of oral diseases. Some of the most common oral diseases include dental cavities, periodontal diseases, oral cancer, malocclusions and other oral diseases and disorders. High prevalence of oral diseases depicts increased demand for orthodontic supplies. According to the World Health Organization (WHO), around 60% to 90% of the school children and nearly 100% of adults suffer from dental cavities. It has also been observed that, around 15% to 20% of adults aged between 35 to 44 years, suffer from severe periodontal (gum) disease.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/orthodontic-supplies-market/report-sample

As per the findings of the research, based on product, the fixed braces held the largest share in the global orthodontic supplies market, primarily due to their efficacy and precision in treating the irregularities in dental structure. Removable braces are expected to register the fastest growth in the orthodontics supplies market during the forecast period. The growth of the removable braces is primarily attributable to increase in the adoption of these braces by adults over traditional braces. Based on end user, children & teenagers are the larger end user in the orthodontic supplies market. Orthodontic treatments are more effective and successful in childhood or teenage as treatment at early age also prevents the development of serious problems, thereby leading to the larger adoption of orthodontic supplies at this age. The orthodontic supplies market for adults is expected to witness higher growth during the forecast period, mainly due to the increasing investment for the development of aesthetic braces and rising awareness about orthodontic treatment.

Cosmetic orthodontics is a procedure where the treatment is done to improve the appearance of a person’s gums, teeth and bite. The primary focus of the treatment is to alter the color, shape, and alignment of the teeth. With the growing inclination towards appearance, cosmetic orthodontics has become a preferable treatment option. Many technological advancements have been made in the orthodontics supplies products to make a person’s appearance better, both during and after the treatment. Some of these advancements include transparent brackets for professional look, colored brackets for children, and lingual brackets.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=orthodontic-supplies-market

Market players in the orthodontic supplies market are offering more advanced orthodontic supplies through increased number of acquisitions and product launches as their key strategies. In February 2017, Align technology, Inc. acquired Invisalign distributor Align Technology Do Brasil LTDA for the Brazil market. This acquisition helped the company to focus on the commercial, marketing and operational needs of doctors and potential patients in Brazil.

Some of the other key players operating in the orthodontics supplies market include 3M Company, Danaher Corporation, G&H Orthodontics Inc., American Orthodontics, TP Orthodontics Inc., Rocky Mountain Orthodontics, Dentaurum GmbH & Co. Kg and DB Orthodontics Inc.

Infection Surveillance Solutions Market - Global Industry Analysis, Growth and Demand, 2023

Infection is the invasion and multiplication of microorganisms such as viruses, bacteria and parasites that are not normally present within the human body. An infection may cause no symptoms and be hidden, or it may cause symptoms and be clinically visible. An infection may remain localized, or it may spread through the blood or lymphatic vessels to become systemic (present in the entire body). The global infection surveillance solutions market is growing due to the emergence of diseases caused by microorganisms that were previously not known. The microorganisms living naturally within the body are not considered as infectious for example, bacteria that normally live within the mouth and intestine such as E. coli do not cause an infection to the body. Hospital associated infections such as urinary tract infection, surgical site infections and pneumonia are increasing due to the use of contaminated devices, patient clothing, and other materials used in hospitals and clinics. This has thus provoked healthcare professionals and hospitals to adopt infection surveillance solutions to identify possible infections during the time the patient remains in hospital, and to develop necessary preventive measures for the same. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sterile medical devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market

The growth in the global infection surveillance solutions market is expected to be mainly due to the increasing incidence of HAIs; policies introduced by government for preventing these HAIs; and increase in expenditure in healthcare sector. According to World Health Organization (WHO), 9.9% of the gross domestic product (GDP) of the world was spent on healthcare in 2014. Furthermore, cost-effectiveness, and redundancy of clinical data and the increase in number of surgeries drive the growth of infection surveillance solutions market.

The introduction of cloud-based software into the infection surveillance solutions market and high growth in developing countries across Asia-Pacific and Latin America provide vast area of opportunities for players in the infection surveillance solutions market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market/report-sample

The key trend noticed in infection surveillance solutions market is the shift of healthcare providers towards automation in healthcare facilities and a growing demand for web-based solutions and mobile platforms. 

Some of the other key players in global market are, Premier Inc., Baxter International Inc., Gojo Industries, Inc., Truven Health Analytics (An IBM Company), DEB Group Ltd., Hygreen, Inc., Atlas Medical Software, and RL Solutions.

Europe Hospital Beds Market Regional Analysis with Type, Top Manufacturers, Demand, Applications till 2022

The European hospital bed market achieved a value of $1.6 billion in the year 2015 and is forecasted to grow at a CAGR of 4.3% during 2016-2022. Depending upon the usage, there are variety of hospital beds that are available in the regional market such as general, birthing, pediatric, bariatric, pressure relief and others. Amongst the various types, general beds held the largest share of the market, and is expected to attain a value of $854.4 million by 2022, growing at a CAGR of 4.8%. The category is also expected to witness the fastest growth during the forecast period, since general beds are used for all types of patients. The hospital bed market in the region has been growing due to several factors such as increasing healthcare expenditure, growing aging population, increasing prevalence of chronic diseases and ongoing technological advancements the market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/europe-hospital-beds-market

The government of various countries are investing in healthcare expenditure, due to which the companies are focusing more on providing best facilities to the patients by developing innovative solutions for better care. For instance, in May 2017, Hill-Rom Holdings, Inc., unveiled its new Hill-Rom Envella Air Fluidized Therapy Bed, which is an advanced solution for wound care for patients with advanced wounds. The Envella bed's differentiated technology provides an ideal healing environment for the prevention and treatment of advanced pressure injuries. Following that Howard Wright Limited launched a new ward bed M10, in July 2016, which can revolutionize patient care and safety. M10 has the most demanding standards and is made to focus on three key areas of concern namely, patient falls, pressure injuries and cross infection.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/europe-hospital-beds-market/report-sample

Some of the key players operating in the regional hospital bed market are Hill-Rom Holdings, Inc., Stryker Corporation, Getinge AB, LINET spol. s.r.o., Howard Wright Limited, Drive DeVilbiss Healthcare, Sunflower Medical Ltd., Stiegelmeyer GmbH & Co. KG, Merivaara Corp., and Alpha-Fit GmbH.

Mobile Health Industry Trends, Analysis, Growth and Future Scope

Mobile health market was valued at $13,674.3 million in 2015, and it is expected to grow at a CAGR of 34.0% during 2016 - 2022. Among the various products and services, the mHealth application segment is expected to witness the fastest growth, at a CAGR of 40.1%, during the forecast period. The global mhealth market is growing at a significant rate, due to increasing healthcare cost, increasing demand for patient centric healthcare model, and increasing prevalence of chronic and lifestyle associated diseases. In addition, the growing demand for mhealth technologies, increasing access of mobile platforms, tablets and smartphones, increasing utilization of connected medical devices and mhealth applications, and growing need for remote patient monitoring services are also driving the growth of the global mhealth market.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/mobile-healthcare-market

Mobile health (mHealth) is the use of mobile information and communication technologies for improving healthcare. It helps to tackle major challenges faced by the healthcare industry such as regulatory changes, continuous remote monitoring at home, increasing demand for quality healthcare, increasing error occurrence and integration with existing IT systems.

Geographically, North America dominated the global market of mhealth in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, CAGR of 40.5%, during the forecast period.

Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/mobile-healthcare-market/report-sample

Some of the key companies operating in the global mhealth market include LifeWatch AG, Cisco Systems Inc., Cerner Corporation, OMRON Corporation, AT&T Inc., athenahealth Inc., Airstrip Technologies Inc., AliveCor Inc., AgaMatrix Inc., iHealth Labs Inc., Koninklijke Philips N.V., BioTelemetry Inc., Medtronic PLC, Withings SAS, and Johnson & Johnson.

Breast Cancer Market - Global Industry Analysis, Size and Growth, 2023

Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular carcinoma and invasive ductal carcinoma.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market/report-sample

DCIS, also known as intraductal carcinoma, begins in the lining of the milk ducts. Milk ducts are thin tubes carrying milk from lobules of the breast to the nipple. Lobule carcinoma originates in the lobules or milk glands of the breast. Invasive ductal carcinoma is the most common type of breast cancer. It starts in a milk duct of the breast, ruptures through the wall of the duct and grows into the fatty tissue of the breast. It spreads to other parts of body through bloodstream.

The global breast cancer market covers various diagnostic technologies and therapeutic drugs. Diagnostic segment is further sub-segmented into various tests which are used to diagnose breast cancer. Some of the major diagnostic tests are biopsy, mammography, MRI, etc. Therapeutic segment covers hormone therapies and chemotherapy drugs. Some of the major drugs are Trastuzumab, Bevacizumab, Anastrozole, Capecitabine, Carboplatin, Denosumab, Docetaxel, Doxorubicin, Eribulin, Exemestane, Fluorouracil, Fulvestrant, Gemcitabine, Ixabepilone, Lapatinib, Letrozole, Methotrexate, Paclitaxel and Tamoxifen.

For more information visit: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market

Some of the major competitors in the market are Astrazeneca PLC, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Novartis AG, Sanofi-Aventis. Pfizer, Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.

Healthcare/Medical Simulation Market Analysis, Size, Growth and Demand, 2023

The global healthcare/medical simulation market is growing significantly due to technological advancements and increasing demand for minimally invasive procedures. Massive unexplored healthcare/medical simulation market in emerging economies and lack of service providers are creating ample opportunities for the global healthcare/medical simulation market to grow at a considerable rate in the coming years. However, lack of adequate input data for medical simulation models is a major challenge in the global healthcare and medical simulation market. Medical simulation trains medical professionals to minimise errors during surgical procedures by using advanced techniques of simulation. The simulated animations help students to understand the complexity of medical procedures through computer-based virtual patients.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/healthcare-simulation-market/report-sample

Adoption of medical simulation technology in hospitals and academic institutes worldwide in order to reduce the medical errors and improve patient safety is a trend in healthcare/medical simulation market. Deaths occurring due to medical mistakes are major concern across the globe. According to a report published in September 2013, in the Journal of Patient Safety, more than 440,000 people die every year due to preventable medical errors. Healthcare simulation may simulate critical medical conditions without any harm to patients; this in turn helps medical professionals to evaluate their practices and reduce their mistakes. Medical simulation is capable of reproducing critical events over and over again and hence, explores consequences of each error or mistake made.

Geographically, North America will be leading the global healthcare/medical simulation market in the coming years, due to technological advancements, high healthcare expenditure, and presence of a large number of hospitals and academic institutions. In addition, Patient Safety and Quality Improvement Act in the U.S. is also driving its market in North America region. Asia-Pacific is the fastest growing region in the global healthcare/medical simulation market. The major reasons for the fastest growth in the region are improving healthcare infrastructure and increasing demand for minimally invasive procedures.

Explore Report at: https://www.psmarketresearch.com/market-analysis/healthcare-simulation-market

Some of the major players operating in the global healthcare/medical simulation market are Laerdal Medical As, 3D Systems, Inc., CAE, Inc., Kyoto Kagaku Co., Ltd., Limbs & Things, Ltd., Gaumard Scientific Company, Inc., Simulab Corporation, Surgical Science Sweden Ab, and Mentice Ab.

Biosimulation Technology Market - Global Industry Insights, Analysis and Growth, 2023

The global biosimulation market is growing significantly due to technological advancements and increasing research and development investment in the pharmaceutical and biotechnology industries. Low success rate of drug approval and emerging software applications of biosimulation technology are creating ample opportunities for the global biosimulation technology market to grow at a significant rate in the forecasted period.The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective biosimulation software.

In biosimulation industry, there is a trend of collaboration and partnership of universities and research institutes with suppliers. Drug discovery and development process is stringent, time consuming, and expensive process. In addition, the success rate of drug approval is very low. According to Tufts Centre for the Study of Drug Development, an academic, non-profit research group at Tufts University, in the U.S., out of 1,000 compounds tested only one makes it to human clinical trials, and out of five such compounds only one gets approved. Biosimulation technology overcomes these limitations by simulating biological systems through software models and increasing predictability in early stages of drug development; hence, saving time and money in drug development process.

Explore Report at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market

Biosimulation technology market can be categorized on the basis of applications, end-users, and product types. Based on applications, the biosimulation technology market can be categorized as drug development, drug discovery, and others. Drug development segment includes preclinical testing and clinical trials; whereas, drug discovery segment includes target identification and validation, and lead identification and optimization. Drug development segment leads the biosimulation technology market. Based on end-users, biosimulation technology market can be categorized as pharmaceutical and biotechnology companies, academic institutes and research laboratories, contract research organizations, and others. Pharmaceutical and biotechnology companies lead the biosimulation technology market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market/report-sample

Some of the major players operating in the global biosimulation technology market Dassault Systemes SA, Simulation Plus Inc., Certara USA, Inc., Advanced Chemistry Development, Inc., In Silico Biosciences, Inc., Chemical Computing Group, Inc., Physiomics PLC., Rhenovia Pharma Ltd., Genedata AG, Entelos Holding Corporation, Leadscope, Inc., and Schrodinger Inc. among others.

Key Growth Factors in Vaccine Market that has a huge impact on Medical Industry

The global vaccine market is growing significantly due increasing initiatives by non-government organizations to provide immunization and improvement in production technique of vaccine in the industry. Various programs and campaigns are organized, such as Immunization Week by World Health Organization, to create awareness among the population all over the world. Massive unexplored market in vaccine industry of developing economies are creating ample opportunities for the vaccine market to grow at a considerable rate in the coming years.

Explore Report at: https://www.psmarketresearch.com/market-analysis/vaccine-market

Moreover, the advanced research and development facilities, and new and innovative product developments by the companies are propelling the growth of the vaccine industry. Increasing prevalence of cancer and infectious diseases is fuelling the growth of the vaccine market. Infectious diseases are the major contributor to the human mortality and morbidity. According to World Health Organization, approximately 129,064 cases were reported in 2013. Vaccination has rescued millions of lives to provide secure and better life.

The vaccine market is categorized on the basis of type, technology, disease indication and end users. On the basis of type of vaccine, the vaccine market can be categorized as preventive vaccine and therapeutic vaccine. Preventive vaccine leads the vaccine market due to increasing prevalence of infectious disease and increasing investment by government and non-government organizations.

Explore report Sample at: https://www.psmarketresearch.com/market-analysis/vaccine-market/report-sample

Some of the companies operating in the global vaccine market are GlaxoSmithKline, Plc., CSL Limited, Sanofi, Medimmune, LLC., Emetgent Biosolutions, Inc., Novartis, AG, Pfizer, Inc., Merck & Co., Inc., Bavarian Nordic, and Johnson & Johnson.

Infertility Treatment Market - Global Industry Size, Share and Growth, 2023

Infertility is a condition where, a person is unable to reproduce by natural means. Treatment of the infertility depends on the cause of the condition. The various causes of infertility include sexually transmitted infections, genetic problems, DNA damage due to smoking, diabetes mellitus, and toxins such as chemical dusts, glues and pesticides. According to the Center for Disease Control and Prevention (CDC), there are around 6.9 million women aged 15-44 years, who have ever used infertility services. The global infertility treatment market is increasing significantly due to the changing lifestyle and exposure to harmful chemicals via pollution.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/infertility-treatment-market/report-sample

On the basis of procedure, the infertility treatment market is segmented into assisted reproductive technology (ART), artificial insemination, fertility surgeries, and other procedures such as egg freezing, sperm freezing, and embryo freezing. Assisted reproductive technology (ART) held the largest share of the market in 2016, due to the technological advancements and high prevalence of lifestyle disorders which is further leading to a decline in the fertility rate.

infertility treatment market is expected to grow significantly during the forecast period (2017-2023). The major factors driving growth of the infertility treatment market are continuous decline in fertility rates, high prevalence of lifestyle disorders, growing public awareness about infertility and the available treatment options, and technological advancements in infertility treatment devices.

Smoking is one of the major reasons for the decline in fertility rates and high prevalence of lifestyle disorders. According to the Center for Disease Control & Prevention (CDC), smoking kills more than 480,000 people every year in the U.S. Smoking reduces fertility in female ovocytes and in male sperm. As per the reports of World Health Organization (WHO), every year tobacco kills more than 7 million people worldwide. Thus, the various disorders caused by the smoking and decline in the fertility rate are driving the growth of the infertility treatment market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/infertility-treatment-market

Some of the key players in the infertility treatment market include Cooper Companies Inc., Cook Group Incorporated, Vitrolife AB, Genea Limited, Irvine Scientific, The Baker Company, Inc., IVFtech ApS, Esco Micro Pte. Ltd., Thermo Fisher Scientific, Inc., and Labotect GmbH.

Medical Tapes and Bandages Market Analysis, Size, Growth and Opportunities, 2023

Medical Tapes are used as a medicine and first aid to hold a bandage or other dressing onto a wound. These tapes are designed to hold firmly to skin, dressing materials, and underlying layers of the skin (due to the presence of adhesive), without damaging the skin, and allow air to pass through them and reach the skin. Some breathable tapes such as Kinesiology Tape, and other elastic bandages with adhesives, are made of cotton. Surgical tape is often white because it contains zinc oxide, which is added to prevent infections. The global medical tapes and medical bandages market, is expected to grow in the forecast period due to increasing number of surgeries and growth in aging population. Medical bandages are generally used to support a medical device such as dressing or splint or to restrict the movement of any part of the body. Some of the other medical tapes used include micropore paper tape, trans-pore polyethylene tape and zinc oxide tape.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/medical-tapes-and-bandages-market/report-sample

The medical tapes and bandages market is divided on the basis of product, application and end user. On the basis of product, the market is segmented into medical tapes and bandages. Further types of medical bandages include gauze bandages, adhesive bandages, cohesive and elastic bandages, and other medical bandages. Medical tapes are further segmented as fabric tapes, paper tapes, plastic tapes, and other medical tapes. Medical bandages held the largest share of the global medical tapes and bandages market, in 2016, due to high number of surgical procedures, increasing aging population, and a rise in the number of various medical conditions that require surgical intervention.

The rise in the number of surgeries performed, rapid growth in geriatric population and rising cases of chronic wounds are the factors driving the growth of the medical tapes and bandages market, during the forecast period. According to the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing at a high rate. The number of people aged 60 years or over is projected to grow by 56.0 % globally, i.e. from 901 million in 2015 to 1.4 billion by 2030, and is projected to more than double its size of 2015, to reach 2.1 billion by 2050. Additionally, according to the World Bank, 30,537 surgeries were performed per 100,000 population, in the U.S., in 2012. Similarly, in 2015, number of surgical procedures performed in Australia was 28,907, per 100,000 population. According to a publication by the World Health Organization (WHO), in 2016, around 266.2 to 359.5 million surgeries were performed, globally, in 2012.

Explore Report at: https://www.psmarketresearch.com/market-analysis/medical-tapes-and-bandages-market

Some of the other key players operating in the medical tapes and bandages market are Beiersdorf AG, Covidien PLC (Medtronic PLC), Johnson & Johnson, Smith & Nephew PLC, Medline Industries, Inc., B. Braun Melsungen AG, Cardinal Health, Inc., Nitto Denko Corporation, BSN Medical GmbH (A Part of Svenska Cellulosa Aktiebolaget (SCA)) and Derma Sciences, Inc. (Integra Lifesciences Holdings Corporation).

Immune Checkpoint Inhibitors Market - Pipeline Analysis, Growth and Demand, 2023

The global immune checkpoint inhibitors market is expected to witness significant growth as these are proven to be more effective therapy in shrinking tumor in higher proportion of patients, as compared to other immunotherapies. Immune checkpoint inhibitors are applicable to a wider range of tumor types such as advanced or metastatic non-small cell lung cancer, renal cancer and melanoma. These inhibitors lower the rate of severe toxicities and immune-mediated side-effects. These are also convenient to administer and yield a good response rate of any single-agent immunotherapy.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/immune-checkpoint-inhibitors-market/report-sample

Immune checkpoints comprised of cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitors and PD-1 and PD-L1 inhibitors. CTLA-4 drug are molecules used to regulate, stimulate or inactivate the immune cells. PD-1 is found on the surface of cancer cells and it is used by tumors to evade the immune system; therefore, PD-1 inhibitor blocks PD-1 action and enables the body to attack and kill cancer cells. PD-L1 is a transmembrane protein of 40kDa that helps in suppressing the immune system during tissue allograft, pregnancy, autoimmune disease, hepatitis and other diseases.

Immune checkpoint inhibitors are showing good efficacy with PD-1 and PD-L1 inhibitors and CTLA-4 inhibitors. Yervoy, an anti-CTLA-4 product of Bristol-Myers Squibb Company got approved in the year 2011. The increased use of combination therapy of PD-1 and PD-L1 inhibitors represent a new signal of immunotherapeutics, which is expected to alter the standard of care for cancer across the globe. However, the development of effective immunotherapy presents some challenges due to complex pathophysiology of cancer and difficulty in managing treatment related toxic effects, which is expected to hamper the growth of the global market to some extent.

Explore Report at: https://www.psmarketresearch.com/market-analysis/immune-checkpoint-inhibitors-market

Some of the key players operating in the global market are Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Pfizer Inc., F. Hoffmann-La Roche AG, Novartis AG, Regeneron Pharmaceuticals, Inc., Ono Pharmaceutical Co., Ltd., and TG Therapeutics, Inc.

NASH Therapeutics Market - Global Industry Analysis, Size, Growth and Demand, 2023

The global nonalcoholic steatohepatitis therapeutics market is expected to witness significant growth due to current unmet medical need of NASH, scarcity of the permanent treatment of the disease, increasing prevalence of obesity, and high demand for safe and effective medication. The regulatory bodies are supporting the NASH market by providing designations and funding for speeding up the drug development process. In March 2015, obeticholic acid, an investigational Phase III clinical trial drug candidate of Intercept Pharmaceuticals Inc., received breakthrough therapy designation from the U.S. Food and Drug Administration for the treatment of patients with NASH.

Explore Report at: https://www.psmarketresearch.com/market-analysis/nash-therapeutics-market

The pipeline of NASH therapeutics is rich with more than 50 drugs. The pharmaceutical companies are actively involved in the research and development of drug for NASH. In June 2016, The Zydus Cadila initiated Phase III clinical trials of Saroglitazar to study its effect in adult NASH patients.

NASH is a type of liver disease, which is characterized by liver inflammation and fat accumulation, in the absence of significant alcohol consumption. It is the more severe form of nonalcoholic fatty liver disease. In NASH, fat accumulation, hepatic inflammation and hepatic triglyceride accumulation may ultimately lead to liver cirrhosis. North America is an emerging epidemic of obesity due to NASH. According to the NIH, NASH affects 2% to 5% of Americans and it is one of the major causes of cirrhosis.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/nash-therapeutics-market/report-sample

A large number of pharmaceutical companies are investing huge capital for the development of NASH therapeutics. However, certain factors such as unknown etiology, complex pathophysiology, and high treatment cost of NASH are expected to hamper the growth of the global market during the forecast period.

Some of the key players operating in the global NASH therapeutics market are Genfit SA, Gilead Sciences, Inc., Novo Nordisk A/S, Intercept Pharmaceuticals, Inc., Enzo Biochem, Inc., Raptor Pharmaceutical Corp., Conatus Pharmaceuticals Inc., Zydus Cadila Healthcare Limited., Novartis AG, and Shire plc.

Blood Collection Market Outlook, Trends, Analysis and Growth, 2023

The global blood collection market is witnessing considerable growth due to increasing geriatric population, increasing number of accidental cases and growing surgical procedures. Moreover, growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and infectious diseases is supporting the growth of the market. Based on product type, the blood collection needle and syringe segment lead the market. The increasing demand of needle and syringe for blood collection across the globe, owing to their easy availability and ease of use, is driving the growth of this segment. In addition, rising initiatives undertaken by government associations to boost awareness about blood donations and advanced features of blood collection products are also supporting to the growth of this market.

Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/blood-collection-market/report-sample

The use of RFID technology in blood banks and transfusion medicine has the potential to improve operational efficiency. It helps in providing patient safety at point of care by automatically identifying, reconciling, and tracking blood products throughout the blood supply chain. The increasing use of radiofrequency identification (RFID) and needle free devices is expected to create opportunities for the manufacturers of blood collection products. However, risk associated with blood transfusions and growing needlestick injuries are the key factors hampering the growth of the global market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/blood-collection-market

The key players operating in the global blood collection market are Abbott Laboratories Inc., Becton, Dickinson and Company, Terumo Corporation, Sarstedt AG & Co., Nipro Medical Corporation, Qiagen, Haemonetics Corporation, Greiner Holding AG and F.L. Medical SRL.

Cartilage Repair Market - Global Industry Size, Trends and Growth, 2023

The global cartilage repair market is witnessing considerable growth due to increasing geriatric population, increasing obesity, increasing healthcare expenditure, and growing sports related injuries. Moreover, increase in innovative product launches and growth of medical tourism leading to awareness about the cartilage treatment modalities across the globe is supporting the growth of the market. Based on the treatment modalities, cell-based approaches segment is expected to grow at the fastest rate during the forecast period, due to long term results of this treatment.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/cartilage-repair-market/report-sample

The rapid growth in emerging economies and technological advancement in cartilage repair and regeneration products is expected to create opportunities for the manufacturers of cartilage repair products across the globe. However, the high cost of these products and lack of reimbursement for these treatments are the key factors hampering the growth of the global market.

Obesity is a serious health concern in the U.S. The increasing prevalence of obesity is driving the growth of the cartilage repair market in the U.S. According to CDC, during 2011-2012, 35.1% of adult aged 20 years or above were obese. In addition, as published by the Organization for Economic Cooperation and Development (OECD) in the year 2014, the obesity rate in Germany increased from 11.5% in 1999 to 14.7% in 2009. This increase in obesity rate leads to increase in demand for liposuction procedures, which is further accelerating the market growth.

Explore Report at: https://www.psmarketresearch.com/market-analysis/cartilage-repair-market

The key players operating in the global cartilage repair market are Zimmer Biomet Holdings, Inc., Johnson & Johnson, Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., RTI Surgical, Conmed Linvatec, B. Braun Melsungen AG, Anika Therapeutics S. R. L.  and Arthrex, Inc.